Pharmacodynamic interaction between RP 59500 and gram-positive bacteria infecting fibrin clots.

Eitemau Tebyg

• Pharmacodynamics of RP 59500 alone and in combination with vancomycin against Staphylococcus aureus in an in vitro-infected fibrin clot model.
  gan: Kang, S L, et al.
  Cyhoeddwyd: (1995)
• Pharmacodynamics of RP 59500 (quinupristin-dalfopristin) administered by intermittent versus continuous infusion against Staphylococcus aureus-infected fibrin-platelet clots in an in vitro infection model.
  gan: Rybak, M J, et al.
  Cyhoeddwyd: (1997)
• In vitro activity of RP59500, an injectable streptogramin antibiotic, against vancomycin-resistant gram-positive organisms.
  gan: Collins, L A, et al.
  Cyhoeddwyd: (1993)
• Pharmacokinetic/Pharmacodynamic Analysis of Tedizolid Phosphate Compared to Linezolid for the Treatment of Infections Caused by Gram-Positive Bacteria
  gan: Rodríguez-Gascón, Alicia, et al.
  Cyhoeddwyd: (2021)
• Penetration of cefixime into fibrin clots and in vivo efficacy against Escherichia coli, Klebsiella pneumoniae, and Staphylococcus aureus.
  gan: Bergeron, M G, et al.
  Cyhoeddwyd: (1986)